UBE2T and colorectal carcinoma: Additionally, upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) has been associated with chemoresistance in CRC, as UBE2T enhances Wnt/β-catenin signaling, promoting resistance 5.